Rule 480-34-.04 - Synthetic Cannabinoids(1) This rule was adopted to protect the health, safety, and welfare of the public. This rule places newly identified compounds, including any material, compound, mixture, or preparation which contains these substances or their derivatives, salts, isomers, or salts of isomers, halogen analogues, and/or homologues, collectively known as Synthetic Cannabinoids, under Schedule I, of the Georgia Controlled Substances Act, Code Section 16-13-25(12)as follows: (M) (1-Pentylindol-3-yl)-(2,2,3,3-tetramethylcyclopropyl) methanone (UR-144) (N) [1-(5-fluoropentyl)indole-3yl]-(2,2,3,3-tetramethylcyclopropyl) methanone (XLR11)(O) [1,1'-biphenyl]-3-yl-carbamic acid, cyclohexyl ester (URB602)(P) [1-(2-morpholin-4-ylethyl)-1H-indol-3-yl]-(2,2,3,3-tetramethylcyclopropyl) methanone (A-796,260)(Q) [3-(3-carbamoylphenyl)phenyl] N-cyclohexylcarbamate (URB597).(R) 6-methyl-2-[(4-methylphenyl)amino]-1-benzoxazin-4-one (URB754)(S) 1-pentyl-N-tricyclo[3.3.1.13,7]dec-1-yl-1H-indazole-3-carboxamide (AKB48)(T) 1-pentyl-3-(1-adamantylamido)indole (2NE1)(U) 1-(5-fluoropentyl)-N-tricyclo[3.31.13,7]dec-1-yl-1H-indole-3-carboxamide (STS-135)(V) 1-naphthalenyl[4-(pentylox)-1-naphthalenyl]-methanone (CB-13)(W) (1-(5-chloropentyl)indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone (5-Chloro-UR-144)(X) (1-(5-bromopentyl)indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone (5-Bromo-UR- 144) (Y) N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-pentyl-1H-indole-3-carboxamide (ADBICA)(Z) N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(5-fluoropentyl)-1H-indole-3-carboxamide (5-Fluoro-ADBICA) (aa) N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(5-fluoropentyl)-1H-indole-3-carboxamide (5fluoro-ABICA)(bb) (1-(4-fluorobenzyl)-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone (FUB-144)(cc) N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(5-fluoropentyl)-1H-indole-3-carboxamide (5-fluoro-ABICA);(dd) 1-naphthalenyl(1-pentyl-1H-indazol-3-yl)-methanone (THJ 018);(ee) 1-(cyclohexylmethyl)-8-quinolinyl ester-1H-indole-3-carboxylic acid (BB-22);(ff) Naphthalene-1-yl 1-(5-fluoropentyl)-1H-indole-3-carboxylate (NM2201). (2) This rule is based on the following findings of the Board: (a) that Synthetic Cannabinoids have an extremely high potential for abuse;(b) that scientific evidence and scientific knowledge of the pharmacological effects of these compounds demonstrate that the public is at extreme risk if they are not regulated as controlled substances;(c) that the pattern of abuse of these compounds and the scope and significance of that abuse support regulation;(d) that there exists an imminent peril to the public health and welfare with regard to the abuse of these compounds;(e) that these compounds have the same risk to the public health of citizens of the State of Georgia as other substances already contained in Schedule I under the Controlled Substances Act;(f) that these compounds have no known precursor already scheduled under the Act; and(g) that the DEA encourages all states to add these compounds to their respective Controlled Substances Acts while DEA follows its procedures to add such compounds to the Federal Controlled Substances Act under Schedule I.Ga. Comp. R. & Regs. R. 480-34-.04
O.C.G.A §§ 16-13-22, 26-4-28, 50-13-4.
Emergency Rule adopted. F. Jun. 12, 2012; eff. Jun. 11, 2012. Original Permanent Rule entitled "Synthetic Cannabinoids" adopted. F. Aug. 16, 2012; eff. Sept. 5, 2012.Repealed: New rule with same title adopted. F. Nov. 16, 2012; eff. Dec. 6, 2012.Amended: F. Oct. 15, 2013; eff. Nov. 4, 2013.Amended: F. Dec. 19, 2013; eff. Jan. 8, 2014.Amended: F. Jul. 17, 2014; eff. Aug. 6, 2014.Amended: F. Nov. 26, 2014; eff. Dec. 16, 2014.Amended: F. Jan. 20, 2016; eff. Feb. 9, 2016.